Physician profile
Michael Adam Selepec
NPI 1235687690
$2,641.59
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $731 · 2022: $1,029 · 2023: $214 · 2024: $423 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,280.21 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Endoprosthesis |
| Janssen Pharmaceuticals, INC | $302.19 | 2021-2022 | |
| Terumo Medical Corporation | $284.03 | 2021-2025 | Azur Cx Detachable |
| Bolton Medical INC | $233.64 | 2022 | |
| Silk Road Medical, INC. | $119.86 | 2021 | |
| Cook Medical LLC | $115.41 | 2021 | |
| Bard Peripheral Vascular, INC. | $109.81 | 2021-2022 | |
| Kci USA, INC. | $92.90 | 2021 | |
| Medtronic, INC. | $37.03 | 2023 | Endurant Iis |
| Ethicon US, LLC | $29.19 | 2025 | Evarrest, Vistaseal |
| Davol INC. | $22.37 | 2021 | |
| Smith+Nephew, INC. | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Selepec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.